文献速递心力衰竭与心肌病高血压冠心病

高血压冠状动脉微血管功能障碍:亚临床靶器官损伤与心衰的标志

Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.
PubMed 文献 · Eur Heart J · 2020-01-01

本研究纳入194例无射血分数降低或限流性冠脉疾病的高血压患者,用PET测冠脉血流储备(MFR)、超声测整体纵向应变(GLS),随访中位8.75年。适应不良性左室重构与较低MFR和GLS受损相关;MFR与GLS均异常者心衰住院风险显著高于两者正常者(校正HR 3.21,95%CI 1.09-9.45,P=0.034),在适应性重构亚组亦然(校正HR 3.93,95%CI 1.14-13.56,P=0.030)。

要点

  • 高血压患者中,适应不良性左室重构与较低MFR和GLS受损相关。
  • MFR与GLS均异常者心衰住院风险较两者正常者升高约3倍。
  • 适应性重构亚组中MFR与GLS均异常仍与心衰住院风险升高相关。

核心结论

  • 冠状动脉微血管功能障碍与心肌力学异常相关,可基于亚临床靶器官损伤细化高血压患者的心衰风险评估。

研究设计与样本

  • 连续纳入接受症状触发负荷心脏PET-CT及90天内经胸超声心动图、左室射血分数≥40%且负荷总评分<3的患者194例。
  • 随访中位8.75年(Q1-3 4.56-10.04),终点为心衰住院及死亡、心衰住院、心肌梗死或卒中的复合终点。

主要发现

  • 155例为适应性左室重构,39例为适应不良性重构,后者与较低MFR和GLS受损相关。
  • 在整个重构谱中,舒张参数、GLS和N末端B型利钠肽前体与MFR独立相关。
  • 适应不良性左室重构与心衰住院和死亡的校正发生率升高相关。
  • MFR与GLS均异常者较两者正常者心衰住院率更高(校正HR 3.21,95%CI 1.09-9.45,P=0.034)。
  • 在适应性重构亚组中,MFR与GLS均异常者心衰住院风险亦升高(校正HR 3.93,95%CI 1.14-13.56,P=0.030)。

临床怎么用

  • 对高血压患者可考虑联合评估MFR与GLS以识别亚临床靶器官损伤和心衰高危者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Hypertension is a well-established heart failure (HF) risk factor, especially in the context of adverse left ventricular (LV) remodelling. We aimed to use myocardial flow reserve (MFR) and global longitudinal strain (GLS), markers of subclinical microvascular and myocardial dysfunction, to refine hypertensive HF risk assessment. METHODS AND RESULTS: Consecutive patients undergoing symptom-prompted stress cardiac positron emission tomography (PET)-computed tomography and transthoracic echocardiogram within 90 days without reduced left ventricular ejection fraction (<40%) or flow-limiting coronary artery disease (summed stress score ≥ 3) were included. Global MFR was quantified by PET, and echocardiograms were retrospectively analysed for cardiac structure and function. Patients were followed over a median 8.75 (Q1-3 4.56-10.04) years for HF hospitalization and a composite of death, HF hospitalization, MI, or stroke. Of 194 patients, 155 had adaptive LV remodelling while 39 had maladaptive remodelling, which was associated with lower MFR and impaired GLS. Across the remodelling spectrum, diastolic parameters, GLS, and N-terminal pro-B-type natriuretic peptide were independently associated with MFR. Maladaptive LV remodelling was associated with increased adjusted incidence of HF hospitalization and death. Importantly, the combination of abnormal MFR and GLS was associated with a higher rate of HF hospitalization compared to normal MFR and GLS [adjusted hazard ratio (HR) 3.21, 95% confidence interval (CI) 1.09-9.45, P = 0.034), including in the adaptive remodelling subset (adjusted HR 3.93, 95% CI 1.14-13.56, P = 0.030). CONCLUSION: We have demonstrated important associations between coronary microvascular dysfunction and myocardial mechanics that refine disease characterization and HF risk assessment of patients with hypertension based on subclinical target organ injury.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Zhou W, Brown JM, Bajaj NS, et al. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020. PMID: 32221588. doi:10.1093/eurheartj/ehaa191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。